Home
Off-Label Marketing

Posts Tagged ‘Off-Label Marketing’

Celgene Pays $280 Million for Off-Label Marketing of Cancer Drugs

Celgene, a pharmaceutical manufacturer based out of New Jersey, paid $280 million following a whistleblower suit which claimed they promoted their popular cancer drugs for unapproved purposes. The two drugs in question, Thalomid and Revlimid, are Celgene’s highest-grossing products, together accounting for $8.4 billion in annual revenue – an astounding 75% of the company’s profits. […]

Read on

Managing my lawyers, making sure they were focused on my case, and ensuring they dedicated the resources necessary, was part of your role I didn’t even know was an issue.

I’d enthusiastically recommend your firm to anyone considering blowing the whistle on fraud.

Becoming a whistleblower was a huge decision. Your firm made it easy.

It took me a bit too long to make that first call to you, and I am thrilled that I did.

I knew I was doing the right thing, but you had all the information I needed quickly, which helped me make the right decisions.

It’s a hard process, standing up for what’s right, so having your firm alongside me really made a huge difference.

Whistleblowers are better off because you guys exist.

Posts Tagged ‘Off-Label Marketing’

Celgene Pays $280 Million for Off-Label Marketing of Cancer Drugs